Optic Neuritis Drug Among Three Promising Treatments To Secure EMA PRIME Designations

Optic Neuritis On A Tablet Screen
Optic neuritis is a rare, sight-threatening condition (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from R&D

More from Europe